a year ago
LIVN
AnalystsMike PolarkMike Polark's Stock Forecasts
AnalystsMike Polark
Analyst Ranking
Top 20%
#1019 out of 5170 analysts
Average Return
+7.89%
Win Rate
54%36 out of 67
Risk vs Reward
Poor
Good
Mike Polark's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Irhythm Technologies IncIRTC | +149.60% | $75.04 | $187.30 | 2024-10-31 - 2025-10-31 | Buy |
Irhythm Technologies IncIRTC | +123.29% | $73.88 | $164.97 | 2024-08-01 - 2025-08-01 | Buy |
Axonics IncAXNX | +84.73% | $40.59 | $74.98 | 2020-09-01 - 2021-08-31 | Buy |
Inspire Medical Systems IncINSP | +78.63% | $125.15 | $223.56 | 2020-09-01 - 2021-08-31 | Buy |
Livanova PLCLIVN | +76.69% | $46.80 | $82.69 | 2020-09-01 - 2021-08-31 | Buy |
Mike Polark Analyst Color
Get additional color on Mike Polark's coverage of popular stocks
a year ago
ISRG
2 years ago
ISRG
3 years ago
DXCM
Mike Polark's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Medline IncMDLN | 1 | Buy | $47.00 | +10.02% | Initiates Coverage On | a day ago |
Irhythm Technologies IncIRTC | 13 | Buy | $220.00 | +30.19% | Maintains | a month ago |
Inspire Medical Systems IncINSP | 9 | Buy | $180.00 | +85.70% | Maintains | a month ago |
Beta Bionics IncBBNX | 1 | Buy | $20.00 | +13.31% | Initiates Coverage On | 7 months ago |
Livanova PLCLIVN | 9 | Buy | $60.00 | -3.82% | Upgrades | 8 months ago |
Insulet CorpPODD | 2 | Buy | $350.00 | +25.65% | Upgrades | 8 months ago |
Kestra Medical Technologies LtdKMTS | 1 | Buy | $29.00 | +23.88% | Initiates Coverage On | 9 months ago |
Edwards Lifesciences CorpEW | 3 | Sell | $60.00 | -27.72% | Downgrades | a year ago |
Nevro CorpNVRO | 9 | Hold | $6.00 | N/A | Maintains | a year ago |
Resmed IncRMD | 4 | Sell | $180.00 | N/A | Downgrades | a year ago |
Stryker CorpSYK | 1 | Buy | $405.00 | N/A | Initiates Coverage On | a year ago |
Intuitive Surgical IncISRG | 7 | Buy | $503.00 | N/A | Maintains | a year ago |
Silk Road Medical IncSILK | 2 | Sell | $27.00 | N/A | Downgrades | 3 years ago |
Dexcom IncDXCM | 1 | Buy | $121.00 | N/A | Initiates Coverage On | 3 years ago |
Abbott LaboratoriesABT | 2 | Sell | $107.00 | N/A | Maintains | 3 years ago |
Sotera Health CoSHC | 4 | Buy | $25.00 | N/A | Upgrades | 3 years ago |
Masimo CorpMASI | 3 | Buy | $165.00 | N/A | Upgrades | 3 years ago |
Teleflex IncTFX | 2 | Buy | $257.00 | N/A | Maintains | 3 years ago |
Boston Scientific CorpBSX | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Medtronic PLCMDT | 1 | Sell | N/A | N/A | Initiates Coverage On | 4 years ago |
Neuropace IncNPCE | 2 | Buy | $13.00 | N/A | Initiates Coverage On | 4 years ago |
Nyxoah SaNYXH | 1 | Hold | $21.00 | N/A | Initiates Coverage On | 4 years ago |
Abiomed IncABMD | 1 | Hold | $330.00 | N/A | Initiates Coverage On | 4 years ago |
Axonics IncAXNX | 2 | Buy | $69.00 | N/A | Initiates Coverage On | 4 years ago |
Shockwave Medical IncSWAV | 1 | Buy | $255.00 | N/A | Initiates Coverage On | 4 years ago |
Vocera Communications IncVCRA | 2 | Hold | $79.00 | N/A | Downgrades | 4 years ago |
Hill Rom Holdings IncHRC | 5 | Hold | $156.00 | N/A | Downgrades | 4 years ago |
Steris PLCSTE | 1 | Buy | $250.00 | N/A | Maintains | 4 years ago |
Biotelemetry IncBEAT1 | 1 | Hold | $43.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.